World Would Get Healthy On Its Own, Without Doctoring
Move over hydroxychloroquine and ivermectin, two widely extolled prescription medicines used to treat COVID-19 viral infections. A natural cure for COVID-19 that is widely available and affordable for even the poorest of people on the planet has been confirmed by a team of virologists who have spent a lifetime studying the underlying causes of viral infections.
Backed by decades of research and safety data for herpes-family viruses, U.S.-based researchers at Bio-Virus Research Inc, Reno, Nevada, report on the successful treatment of the first 30 frontline doctors and nurses and a thousand-plus patients given the amino acid lysine to prevent and even abolish COVID-19 coronavirus infections at a clinic in the Dominican Republic. Astonishingly, symptoms of COVID-19 are reported to have dissipated within hours of this natural treatment.
The virologists, Drs. Christopher Kagan, Bo Karlicki and Alexander Chaihorsky, strongly suggested the front-line healthcare workers embark on a daily regimen of lysine therapy due to daily exposure to the virus. Their ground-breaking report is published online at ResearchGate.net.
Arginine/lysine balance
Lysine therapy interrupts the replication of viruses, including COVID-19 coronavirus, by countering arginine, an amino acid that fosters the eruption of dormant viruses. Lysine has been safely used for decades to quell herpes virus outbreaks that cause cold sores on the lips (herpes labialis), a treatment pioneered by one of the Bio-Virus Research team members in 1974.
Lysine is available in foods and in concentrated form in inexpensive dietary supplements (250 500-milligram lysine tablets can be purchased for under $5 US or 2-cents per tablet), making affordable lysine therapy possible.
Lysine/arginine imbalance would explain why patients who have been infected with COVID-19…
Read full story [icon name=”arrow-right” prefix=”fas”] Virologists Report Poor Man’s Amino Acid Cure for Covid-19 Would Abolish Need for Vaccines – LewRockwell